Abstract: Histopathological analysis was carried out to determine whether hepatitis B surface antigen with the autopsy diagnoses of chronic hepatitis, cirrhosis and/ or hepatocellular carcinoma declined between the 1964-1973 and 1974-1983 decades. In this study, the liver specimens from 422 autopsy cases at Nagasaki University Hospital were used. All of the 17 cases of acute hepatitis were hepatitis B surface antigen negative. Hepatitis B surface antigen positive rates in chronic hepatitis and hepatocellular carcinoma showed minor changes during 1964-1983. On the other hand, proportions of hepatitis B surfce antigen carriers in cirrhosis and cirrhosis with hepatocellular carcinoma in the recent decade 1974-1983 were found.to decrease compared to the last decade 1964-1973. However, the difference of the hepatitis B surface antigen positive rates in cirrhosis with hepatocellular carcinoma between the 2 periods was marginally significant, but not significant in cirrhosis. A possible explanation may be that many cases of posttransfusion hepatitis in the latter decade are not caused by hepatitis B virus.
INTRODUCTION
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The most plausible explanation for the increased risk of hepatocellular carcinoma is that the acceleration of cellular replication that occurs in cirrhosis enhances the effects of many carcinogens, including hepatitis B surface antigen. Moreover, the oncogenic potential of hepatitis B virus in the development of hepatocellular carcinoma has been reported (Sherlock et al., 1970; Vogel et al., 1970; Charinuvati et al., 1975; Senba et al., 1984 Senba et al., , 1985 .
After the discovery of the Australia antigen (hepatitis B surface antigen) by Blumberg et al. (1967) , the subsequent demonstration by Krugman et al. (1967) , and Prince (1968) that the Australia antigen was specifically associated with type B hepatitis, it was widely assumed that development of efficient screening tests would detect type B hepatitis infection carriers and make possible the eradication of the problem of posttransfusion type B hepatitis by preventing transfusion of hepatitis B virus positive blood. In Nagasaki University Hospital, hepatitis B surface antigen screening test has been performed since 1974. Therefore, the objective of this study is to see whether hepatitis B surface antigen positive rates in chronic hepatitis, cirrhosis, and cirrhosis with hepatocellular carcinoma have changed or not between the 1964-1973 and 1974-1983 decades.
MATERIALS AND METHODS
The liver specimens were collected at Nagasaki University Hospital from 422 autopsy cases of various liver diseases, including acute hepatitis (17 cases), chronic hepatitis (40 cases), cirrhosis (177 cases), cirrhosis with hepatocellular carcinoma (170 cases), and hepatocellular carcinoma without cirrhosis (62 cases). The specimens were fixed in formalin, or sometimes in Zenker's formol and embedded in paraffin for histopathologic study. Sections were cut at 5 micron and stained with hematoxylin-eosin, resorcin fuchsin method for elastic fibers, Mallory's method for collagen fibers, silver impregnation method for reticulum fibers, and orcein method for hepatitis B surface antigen (Senba, 1982) . The criteria of Leevy et al. (1979) and Gibson and Sobin (1978) were applied in assigning the diagnosis of cirrhosis an hepatocellular carcinoma to the tissue.
Statistical calculation was performed using the BMDP (Dixon et al., 1981) on the IBM 4341 system in the Data Center of A-bomb Disaster in Nagasaki University. The statistical method for this study is the Pearson chi-square test for association in contingency table. Table 1 The landmark discovery of the Australia antigen (hepatitis B surface antigen) by Blumberg et al. (1965) and the linking of this antigen to viral hepatitis (Blumberg et al., 1967) provided the cornerstone for the rapid acceleration on our understanding of viral hepatitis in general, and posttransfusion hepatitis in particular. The hepatitis B surface antigen positive cases were increased by such antigen detection, but false-positive reaction occurred frequently (Hollinger et al., 1973) . Further specific methods were developed for recognition of other hepatits B virus antigens (hepatitis B. core antigen and hepatitis B e antigen). The introduction of sensitive assays for hepatitis B surface antigen has resulted in marked· reduction in the incidence of posttransfusion hepatitis (Alter et al., 1975) . Therefore, in this study, proportions of hepatitis B surface antigen carrier in cirrhosis and cirrhosis with hepatocellular carcinonna in the recent decade 1974-1983 were found to decrease compared to the last decade [1964] [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] . The decrease in the hepatitis B surface antigen positive rate from 45% to 36% suggests that infection of type B virus caused by posttransfusion can be prevented in the latter decade. However, the hepatitis B surface antigen positive rates in chronic hepatitis showed minor changes during [1964] [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] [1975] [1976] [1977] [1978] [1979] [1980] [1981] [1982] [1983] . A possible explanation may be that high frequency of hepatitis B virus transmission from the carrier mother to her infant has occurred.
RESULTS
